ModifiedUnitedHealthcarePolicy CS363KY.04

Interspinous Fusion and Decompression Devices (for Kentucky Only)

Medical policy governing use of interspinous fixation (fusion) and interspinous decompression/interlaminar stabilization devices for lumbar spine conditions in Kentucky members; specifies covered indications and states unproven uses that are not medically necessary.

Policy Summary

PayerUnitedHealthcare

PolicyInterspinous Fusion and Decompression Devices (for Kentucky Only)

Policy CodePolicy CS363KY.04

Change TypeDocumentation language addedsupporting sections updated

Effective DateFeb 1, 2026

Next Review DateN/A

Key ActionEnsure patient medical records fully document history, exam, and test results and are legible and available upon request to support medical necessity for interspinous fixation procedures.

SourceLink

POLICY UPDATE CHANGES

Medical records documentation language was added specifying that documentation may be required to assess whether the member meets clinical criteria and must fully support medical necessity.

Definitions updated for Arthrodesis, Interlaminar Lumbar Instrumented Fusion (ILIF), Interlaminar Stabilization Device, and Neurogenic Claudication.

Supporting information sections (Description of Services, Clinical Evidence, FDA, References) were updated to reflect current information.

L1-S1Anatomic levels addressed

Grade 1Max spondylolisthesis for coverage

RCTsRCT evidence cited

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Coverage Criteria — Interspinous Devices

Interspinous fixation (fusion) - Covered when ALL criteria met

Interspinous Fixation (fusion) Devices are considered proven and medically necessary when all of the following criteria are met:

Fusion device coverage criteria: Device is used according to FDA labeled indications, contraindications, warnings, and precautions.

Refer to InterQual CP: Procedures, Interspinous Process Device with or without Open Decompression for medical necessity details.

Clinical presentation: Back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies.

Spondylolisthesis limit: No more than Grade I spondylolisthesis at the operative level.<= Grade I

Surgical use: Device is used as an adjunct to interbody fusion at a single lumbar level (L1–S1).single level L1-S1

Device must be utilized in conjunction with open decortication and fusion or interbody fusion of the same motion segment as applicable per NASS guidance.

Interspinous decompression/interlaminar stabilization - Not medically necessary

Interspinous decompression and interlaminar stabilization systems (without fusion):

Not medically necessary statement: Use of interspinous decompression or interlaminar stabilization devices without fusion for treatment of spine pain or spinal stenosis is considered unproven and not medically necessary due to insufficient evidence of efficacy.

Systematic reviews and evidence assessments report low-quality and limited data; additional well-designed long-term comparative trials are needed.

Interspinous distraction devices (static) — Indications

Covered when ALL of the following are met:

Diagnosis: Clinically symptomatic degenerative lumbar stenosis with neurogenic claudication relieved by lumbar flexion.

Functional thresholds: Patient can sit for at least 50 minutes without pain AND can walk at least 50 feet.sitting >= 50 minutes; walking >= 50 feet

Imaging severity: Mild to moderate stenosis on CT or MRI defined as approximately 25–50% reduction in central or lateral/foraminal diameter compared with adjacent levels.25-50%

Conservative management:

Interspinous fixation devices (used WITH fusion) — Indications and contraindications per NASS

May be considered when used as an adjunct to fusion with robust posterior decortication or interbody fusion for patients with appropriate diagnoses.

Appropriate diagnoses: Stenosis, disc herniation, or synovial facet cysts when fusion is indicated or as an adjunct to cyst excision involving removal of >50% of the facet joint.

Per NASS 2025 coverage recommendations.

Surgical technique requirement: Device must be used in conjunction with robust open laminar and/or facet decortication and fusion, and/or autograft inter- and extra-spinous decortication and fusion, and/or interbody fusion of the same motion segment.

NASS 2025: No literature supports use without open decortication and fusion or interbody fusion.

Contraindications / Not indicated scenarios: Spondylolisthesis > Grade I; bilateral isthmic spondylolysis; significant dynamic instability (e.g., on flexion-extension views); scoliosis or coronal/rotatory instability; fusion required at >1 level; generally not indicated at L5–S1 unless anatomy favorable; complete facet resection unless interbody fusion performed; situations where fusion is otherwise not indicated per NASS guidance.

Use of Interspinous Fixation Devices as an off‑label standalone decompression (i.e., without interbody fusion) is discouraged. The policy notes a specific risk of spinous process fracture when these devices are used alone as spacers, and it also describes a potential for focal kyphosis that could negatively impact the interbody cage and bone graft if an interspinous fixation device is used without a concurrent fusion. These safety concerns underpin the recommendation to avoid off‑label standalone use except within FDA‑labeled indications and supported clinical criteria.

Interspinous distraction (static) devices are not indicated for more advanced deformity or instability. The policy specifies they are not indicated for degenerative spondylolisthesis of Grade II or higher, and they should not be used when degenerative scoliosis exceeds 25°. The devices are also inappropriate when there is dynamic instability at the operative level, symptoms are not relieved by flexion, the patient is medically suitable for direct decompression, a fixed motor deficit is present, or prior lumbar surgery has been performed at the intended level.

Interspinous fixation devices used as an adjunct to fusion have explicit contraindications and situations where they should not be used. They should not be used for spondylolisthesis greater than Grade I, for bilateral isthmic spondylolysis, or when significant dynamic instability (for example on flexion‑extension views) is present. They are generally not indicated when fusion is required at more than one level, and they are typically not suitable for L5‑S1 procedures because of mechanical limitations of the S1 spinous process unless anatomy is clearly favorable. Complete facet resection without interbody fusion and evidence of coronal or rotatory instability are additional scenarios where these devices are contraindicated.

Interspinous decompression and interlaminar stabilization systems used without fusion are declared unproven and not medically necessary for treatment of spine pain or lumbar spinal stenosis because of insufficient evidence of efficacy. The policy references low quality and limited clinical evidence for these devices and requires that interspinous fixation devices be used according to FDA labeling and within the covered fusion indications to be considered medically necessary.

The policy highlights limitations in the evidence base for spacer and decompression devices: systematic reviews and meta‑analyses report predominantly low‑quality studies, small trial sizes, and few long‑term randomized controlled trials. Available analyses show short‑term improvements in some pain measures but inconsistent long‑term benefit and an observed signal for higher rates of reoperation with interspinous spacers compared with standard decompression. Because of these comparative‑effectiveness and safety uncertainties, the policy concludes many uses of interspinous spacer devices remain unsupported as equivalent to gold‑standard decompression.

Coding and Key Parameters

Applicable Codes (reference)CPT

22853

Insertion of interbody biomechanical device(s) (e.g., synthetic cage, mesh) with integral anterior instrumentation for device anchoring (e.g., screws, flanges), when performed, to intervertebral disc space in conjunction with interbody arthrodesis, each interspace (List separately in addition to code for primary procedure)

Applicable Codes (continued)CPT

22854	Insertion of intervertebral biomechanical device(s) (e.g., synthetic cage, mesh) with integral anterior instrumentation for device anchoring (e.g., screws, flanges), when performed, to vertebral corpectomy(ies) (vertebral body resection, partial or complete) defect, in conjunction with interbody arthrodesis, each contiguous defect (List separately in addition to code for primary procedure).
22859	Insertion of intervertebral biomechanical device(s) (e.g., synthetic cage, mesh, methylmethacrylate) to intervertebral disc space or vertebral body defect without interbody arthrodesis, each contiguous defect (List separately in addition to code for primary procedure).
22867	Insertion of interlaminar/interspinous process stabilization/distraction device, without fusion, including image guidance when performed, with open decompression, lumbar; single level.
22868	Insertion of interlaminar/interspinous process stabilization/distraction device, without fusion, including image guidance when performed, with open decompression, lumbar; second level (List separately in addition to code for primary procedure).
22869	Insertion of interlaminar/interspinous process stabilization/distraction device, without open decompression or fusion, including image guidance when performed, lumbar; single level.
22870	Insertion of interlaminar/interspinous process stabilization/distraction device, without open decompression or fusion, including image guidance when performed, lumbar; second level (List separately in addition to code for primary procedure).
22899	Unlisted procedure, spine (when specified as insertion of a non-pedicle interspinous process fixation device)

Nonoperative treatment duration

Required nonoperative treatment durationFailure of 6 months of nonoperative treatment is required before considering interspinous distraction devices.

ContextApplies to static interspinous distraction devices used instead of direct decompression for symptomatic degenerative lumbar stenosis.

Documentation noteMedical records may be required to assess whether the member meets the 6‑month nonoperative therapy criterion.

Maximum degenerative scoliosis

Maximum degenerative scoliosis angleDegenerative scoliosis must be no more than 25° (<= 25°) to meet indications for interspinous distraction devices.

Contraindicated scenario

Provider Actions, Prior Authorization & Documentation

Prior Authorization

Prior Authorization and Applicable CPT Codes

Prior authorization is required for interspinous devices and related procedures. Submit requests with the specific CPT codes listed and supporting clinical documentation to allow review against InterQual® criteria and policy requirements.

Prior authorization required prior to scheduling
Include applicable CPT codes: 22853, 22854, 22859, 22867, 22868, 22869, 22870, 22899
Attach radiology reports and clinical notes supporting diagnosis and prior conservative therapy

Denial Risk

Documentation Insufficiency — Denial Risk

Documentation that is incomplete, illegible, or unavailable upon request may result in denial of the request or claim. Ensure records submitted with prior authorization and for claim adjudication are complete and clear.

Background and Clinical Context

Lumbar spinal stenosis (LSS) is narrowing of the lower‑back spinal canal that can compress nerves controlling leg sensation and movement, producing neurogenic claudication and radicular leg pain that is often relieved by flexion. Surgical options include standard decompressive laminectomy with or without fusion, or fusion procedures with instrumentation. Interspinous devices were developed as less invasive alternatives: interspinous distraction (spacer) devices aim to indirectly decompress neural elements and reduce extension‑related symptoms, whereas interspinous fixation devices are designed to affix to spinous processes to provide stabilization when used as an adjunct to open decortication and interbody fusion. The policy notes biomechanical differences and potential tradeoffs—spacers provide indirect decompression while fixation devices provide stabilization but may be less effective than pedicle screw constructs for controlling rotation and lateral bending, and both device types carry procedure‑specific risks that must be weighed against standard surgical approaches.

Definitions

Interspinous Fixation Devices definition

DefinitionInterspinous Fixation Devices are devices intended for attachment to the spinous processes to achieve stabilization and promote fusion in patients with degenerative disc disease.

Use contextMay be used as an adjunct to interbody or posterior fusion procedures when performed with robust posterior decortication and fusion techniques.

Risk noteOff‑label standalone use (without fusion) is discouraged due to risks such as spinous process fracture and potential focal kyphosis.

Interspinous Process Decompression (IPD) / Interlaminar Stabilization Device definition

DefinitionInterspinous Process Decompression (IPD) / Interlaminar Stabilization Device are implantable spacers inserted between adjacent spinous processes to distract and decompress neural elements, reducing lumbar extension and providing dynamic stabilization.

Policy Summary

PayerUnitedHealthcare

PolicyInterspinous Fusion and Decompression Devices (for Kentucky Only)

Policy CodePolicy CS363KY.04

Change TypeDocumentation language addedsupporting sections updated

Effective DateFeb 1, 2026

Next Review DateN/A

Key ActionEnsure patient medical records fully document history, exam, and test results and are legible and available upon request to support medical necessity for interspinous fixation procedures.

SourceLink

On This Page

Failure of at least 6 months of appropriate nonoperative treatment prior to consideration of device implantation.

Anatomic and instability limits: No more than 25° degenerative scoliosis AND no more than Grade I degenerative spondylolisthesis.scoliosis <= 25°; spondylolisthesis <= Grade I

Surgical suitability: Open decompression (e.g., laminectomy) is not a medically safe option because of patient comorbidities.

Exclusions: Not a candidate if BMI >= 40, fixed motor deficit, prior lumbar surgery at the intended level, symptoms not relieved by flexion, dynamic instability at the operative level, or primarily axial back pain unrelated to activity.BMI < 40

Interspinous distraction devices are not indicated for degenerative spondylolisthesis Grade II or higher or degenerative scoliosis > 25%.

Per NASS 2025 contraindication list.

Degenerative scoliosis > 25° is not an indication for interspinous distraction devices.

Source guidanceNASS 2025 coverage recommendations referenced for scoliosis limits.

Maximum spondylolisthesis grade for indication

Maximum spondylolisthesis gradeIndication limited to degenerative spondylolisthesis Grade I (not Grade II or higher).

Not indicatedDegenerative spondylolisthesis of Grade II or higher is explicitly not indicated.

Related NASS statementNASS 2025 guidance lists spondylolisthesis > Grade I as a contraindication for interspinous fusion devices when used with fusion and for distraction devices without fusion.

Walking/sitting functional thresholds

Sitting tolerance thresholdPatient should be able to sit for at least 50 minutes without pain.

Walking tolerance thresholdPatient should be able to walk at least 50 feet.

Combined functional requirementBoth sitting ≥50 minutes and walking ≥50 feet are part of qualifying functional thresholds for symptomatic degenerative lumbar stenosis.

BMI threshold

BMI exclusion thresholdPatients with BMI ≥ 40 are excluded from indication for interspinous distraction devices.

Documentation requirementMedical records must fully support medical necessity and be legible and available upon request when assessing BMI and other criteria.

Clinical contextBMI ≥ 40 is listed among scenarios where interspinous distraction devices are NOT indicated.

Incomplete or missing medical records may lead to denial

Ensure all submitted documents are legible and available on request

Documentation Required

Medical Record Documentation Requirements

The patient's medical record must contain documentation that fully supports the medical necessity for the requested service. Records should be maintained and made available upon request.

Relevant medical history and physical examination notes
Results of pertinent diagnostic tests or imaging (e.g., MRI, CT) demonstrating stenosis or degeneration
Documentation of symptom pattern (e.g., neurogenic claudication relieved by flexion)
Operative reports and device specifics when applicable
Records of prior nonoperative treatments and response

Prior Authorization

Nonoperative Therapy Requirement

Interspinous distraction devices without fusion require documentation of failure of an adequate course of nonoperative therapy for at least 6 months prior to placement, unless medically contraindicated.

Document at least 6 months of nonoperative treatment and modalities attempted (e.g., physical therapy, medications, injections)
Specify reasons nonoperative care was not tolerated or contraindicated, if applicable

Note

Prior Authorization Guidance & Record Availability

Prior authorization decisions are based on clinical criteria (InterQual®) and the documentation provided. Availability of full medical records upon request is required to complete reviews; lack of access may delay or deny authorization.

Authorization reviewed against InterQual® CP: Procedures, Interspinous Process Device with or without Open Decompression
Provide full records promptly when requested to avoid delays

Often implanted after decompression and intended to relieve extension‑related stenosis; dynamic devices per FDA labeling are used with direct decompression.

Evidence stanceUse without fusion (standalone decompression) is considered unproven and not medically necessary per policy due to limited evidence.

Lumbar Spinal Stenosis (LSS) / Neurogenic Claudication definition

Definition of LSSLumbar Spinal Stenosis (LSS) is narrowing of the lumbar spinal canal that may result in painful compression of nerves causing leg pain, weakness, or claudication.

Neurogenic claudicationNeurogenic claudication: leg pain or weakness relieved by flexion or leaning forward and improved with rest; should be differentiated from vascular claudication.

Clinical relevanceSymptoms relieved by flexion are a qualifying feature for consideration of interspinous distraction devices in symptomatic degenerative lumbar stenosis.

Interspinous distraction (static) device definition

DefinitionInterspinous distraction (static) device: a nonflexible or noncompressible implant intended to provide indirect decompression of neural elements as an alternative to direct decompression.

Intended applicationStatic devices are intended to be used instead of a direct decompressive procedure for select cases of mild‑to‑moderate stenosis.

LimitationsFDA labeling differentiates static versus dynamic devices; static devices are for indirect decompression and have specific qualifying criteria (imaging, function, nonoperative therapy).

Interspinous fixation device (with fusion) definition

DefinitionInterspinous fixation device (with fusion): a device affixing to spinous processes to provide stabilization when used in conjunction with open decortication and fusion or interbody fusion for lumbar fusion procedures.

Appropriate useMay be considered as adjunct to fusion for diagnoses such as stenosis, disc herniation, or synovial facet cysts when used with robust posterior decortication and fusion technique.

ContraindicationsNot indicated for spondylolisthesis > Grade I, bilateral isthmic spondylolysis, significant dynamic instability, scoliosis/coronal instability, fusion at >1 level, and generally not indicated at L5‑S1 unless anatomy favorable.